M.F. Aillaud

2.3k total citations
51 papers, 1.8k citations indexed

About

M.F. Aillaud is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M.F. Aillaud has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in M.F. Aillaud's work include Blood Coagulation and Thrombosis Mechanisms (20 papers), Blood properties and coagulation (11 papers) and Protease and Inhibitor Mechanisms (7 papers). M.F. Aillaud is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (20 papers), Blood properties and coagulation (11 papers) and Protease and Inhibitor Mechanisms (7 papers). M.F. Aillaud collaborates with scholars based in France, United Kingdom and Belgium. M.F. Aillaud's co-authors include I. Juhan‐Vague, Marie‐Christine Alessi, P Vague, A Serradimigni, D Collen, F De Cock, D Collen, Wayne L. Chandler, J Valadier and Paul Holvoet and has published in prestigious journals such as Circulation, Blood and Clinical Infectious Diseases.

In The Last Decade

M.F. Aillaud

51 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.F. Aillaud France 20 843 553 538 348 292 51 1.8k
Amparo Estellés Spain 31 1.1k 1.3× 352 0.6× 477 0.9× 398 1.1× 190 0.7× 84 2.5k
E.J.P. Brommer Netherlands 26 797 0.9× 494 0.9× 335 0.6× 267 0.8× 196 0.7× 75 1.7k
J Aznar Spain 21 898 1.1× 418 0.8× 255 0.5× 394 1.1× 131 0.4× 81 1.8k
EK Kruithof Switzerland 17 1.3k 1.6× 643 1.2× 1.4k 2.6× 301 0.9× 243 0.8× 31 2.6k
D C Stump United States 33 1.0k 1.2× 716 1.3× 701 1.3× 1.2k 3.4× 272 0.9× 67 3.1k
KA Bauer United States 21 1.5k 1.7× 461 0.8× 101 0.2× 520 1.5× 241 0.8× 28 2.3k
Mutsuyoshi Kazama Japan 20 783 0.9× 258 0.5× 115 0.2× 337 1.0× 181 0.6× 80 1.6k
Robert B. Francis United States 20 778 0.9× 244 0.4× 115 0.2× 149 0.4× 261 0.9× 38 1.5k
K. J. Roozendaal Netherlands 20 507 0.6× 260 0.5× 131 0.2× 294 0.8× 189 0.6× 40 1.9k
RD Rosenberg United States 21 1.8k 2.1× 498 0.9× 130 0.2× 528 1.5× 156 0.5× 41 2.5k

Countries citing papers authored by M.F. Aillaud

Since Specialization
Citations

This map shows the geographic impact of M.F. Aillaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.F. Aillaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.F. Aillaud more than expected).

Fields of papers citing papers by M.F. Aillaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.F. Aillaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.F. Aillaud. The network helps show where M.F. Aillaud may publish in the future.

Co-authorship network of co-authors of M.F. Aillaud

This figure shows the co-authorship network connecting the top 25 collaborators of M.F. Aillaud. A scholar is included among the top collaborators of M.F. Aillaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.F. Aillaud. M.F. Aillaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Monneret, Guillaume, Jean‐Paul Mira, M.F. Aillaud, et al.. (2005). Fc RIIIb and Complement Component C7 Codeficiency in a Patient with Recurrence of Fulminant Meningococcal Septic Shock. Clinical Infectious Diseases. 40(11). 1679–1683. 5 indexed citations
3.
Juhan‐Vague, I., Pierre‐Emmanuel Morange, Corinne Frère, et al.. (2003). The plasminogen activator inhibitor-1 −675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study. Journal of Thrombosis and Haemostasis. 1(11). 2322–2329. 43 indexed citations
4.
Aubert, H., Corinne Frère, M.F. Aillaud, et al.. (2003). Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome. Journal of Thrombosis and Haemostasis. 1(4). 791–797. 46 indexed citations
5.
Woodhams, Barry, et al.. (2001). The clinical relevance of the citrate effect on International Normalized Ratio determinations depends on the reagent and instrument combination used. Blood Coagulation & Fibrinolysis. 12(5). 399–404. 5 indexed citations
6.
Chandler, Wayne L., Marie‐Christine Alessi, M.F. Aillaud, P Vague, & I. Juhan‐Vague. (2000). Formation, Inhibition and Clearance of Plasmin in vivo. Pathophysiology of Haemostasis and Thrombosis. 30(4). 204–218. 37 indexed citations
7.
Aillaud, M.F., K. W. E. Denson, Marilyn Johnston, et al.. (1999). Influence of Three Types of Automated Coagulometers on the International Sensitivity Index (ISI) of Rabbit, Human, and Recombinant Human Tissue Factor Preparations. Thrombosis and Haemostasis. 81(1). 66–70. 23 indexed citations
8.
Disdier, P., Lucile Andrac‐Meyer, M.F. Aillaud, et al.. (1996). [Anetoderma during antiphospholipid syndrome. 3 cases].. PubMed. 123(12). 800–3. 8 indexed citations
9.
Robert, Annie, et al.. (1996). Anticoagulant Response to Agkistrodon Contortrix Venom (ACV test): a New Global Test to Screen for Defects in the Anticoagulant Protein C Pathway. Thrombosis and Haemostasis. 75(4). 562–566. 29 indexed citations
10.
Fossat, C., David Fabre, Yves Alimi, et al.. (1995). Leukocyte Activation Study During Occlusive Arterial Disease of the Lower Limb. Journal of Cardiovascular Pharmacology. 25. S96–S100. 15 indexed citations
11.
Gandrille, Sophie, Martine Alhenc‐Gelas, Pascale Gaussem, et al.. (1993). Five novel mutations located in exons III and IX of the protein C gene in patients presenting with defective protein C anticoagulant activity. Blood. 82(1). 159–168. 23 indexed citations
12.
Juhan‐Vague, I., et al.. (1992). Daytime Fluctuations of Plasminogen Activator Inhibitor 1 (PAI-1) in Populations with High PAI-1 Levels. Thrombosis and Haemostasis. 67(1). 76–82. 31 indexed citations
13.
Grob, Jean‐Jacques, Marco Manfredini, M.F. Aillaud, et al.. (1991). Unfading acral microlivedo. Journal of the American Academy of Dermatology. 24(1). 53–58. 13 indexed citations
14.
15.
Aillaud, M.F., D Reviron, Marie‐Christine Alessi, et al.. (1990). Lupus anticoagulants and antiphospholipid antibodies: Comparison of clotting tests with an immunological assay. Thrombosis Research. 60(2). 181–183. 1 indexed citations
16.
Juhan-Vague, I., Antoine Élias, M.F. Aillaud, et al.. (1988). Treatment of deep vein thrombosis with a very low molecular weight heparin (CY 222 - Choay): Thrombolysis and plasma fibrinolytic parameters. Fibrinolysis and Proteolysis. 2(1). 25–29. 4 indexed citations
17.
18.
Aillaud, M.F., I. Juhan‐Vague, Marie‐Christine Alessi, et al.. (1985). Increased PA-Inhibitor Levels in the Postoperative Period – No Cause-Effect Relation with Increased Cortisol. Thrombosis and Haemostasis. 54(2). 466–468. 60 indexed citations
19.
Juhan‐Vague, I., et al.. (1984). Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions. Thrombosis Research. 33(5). 523–530. 208 indexed citations
20.
Juhan-Vague, I., et al.. (1984). Effect of 24 Hours of Normoglycaemia on Tissue-Type Plasminogen Activator Plasma Levels in Insulin Dependent Diabetes. Thrombosis and Haemostasis. 51(1). 97–98. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amparo Estellés Breakdown of academic impact, for papers by E.J.P. Brommer Breakdown of academic impact, for papers by J Aznar Breakdown of academic impact, for papers by EK Kruithof Breakdown of academic impact, for papers by D C Stump Breakdown of academic impact, for papers by KA Bauer Breakdown of academic impact, for papers by Mutsuyoshi Kazama Breakdown of academic impact, for papers by Robert B. Francis Breakdown of academic impact, for papers by K. J. Roozendaal Breakdown of academic impact, for papers by RD Rosenberg
Rankless by CCL
2026